The Cancer Consortium

Cancer News & Information Center

Friday, October 30th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

CivaTech Announces $2.72M Debt Financing

By Alexandra Barnes on December 18, 2016

CivaTech Oncology, Inc., Corporation, a North Carolina-based company focused on localized radiation therapy, submitted a Form D for a $2.72M debt financing. The date of first sale was December 9, 2015, where […]

Creatv’s Early Detection of Cancer and Personalized Cancer Diagnostics

By Alexandra Barnes on December 8, 2016

Creatv MicroTech is a company that understands that cancer will, at some point, likely touch us, our families and friends. In the U.S. alone, 43% of men and 38% of women will […]

CivaTech’s Radiation Therapy Reduces Side Effects

By Alexandra Barnes on December 8, 2016

CivaTech Oncology, Inc. (“CivaTech” or the “Company”) has developed a major technological advance in the radiation treatment of cancerous tumors. CivaTech products significantly reduce the side effects experienced from traditional implantable radiation […]

Valisure’s Cutting-Edge Lab Testing Technology

By Alexandra Barnes on December 7, 2016

Valisure is a start-up company founded in 2015 in New Haven, CT by a group of Yale and Harvard alumni with proven biotech industry success (recent exit: Ion Torrent $725M). Valisure’s disruptive […]

CancerVacs’ Antigens Activate Anti-Tumor Immunity

By Alexandra Barnes on November 27, 2016

CancerVacs is developing intralymphnode immunotherapeutics for certain metastatic cancer patients with no therapeutic options. This includes disseminated follicular lymphoma, glioblastoma multiforme, metastatic castrate-resistant prostate carcinoma, malignant melanoma, or other metastatic solid tumor. […]

Dr. Amit Vohra – Promaxo’s MRI for Prostate Cancer Diagnosis

By Alexandra Barnes on November 26, 2016

Dr. Amit Vohra is the founder & CEO of Promaxo, a company tackling prostate disease management through the development of an office-based MRI. Brett Johnson interviewed Dr. Vohra to find out in […]

OncoTAb awarded National Cancer Institute contract for breast cancer therapy

By Alexandra Barnes on November 25, 2016

OncoTAb, Inc. announced that the company was named as a recipient of a $300,000 grant by the National Cancer Institute (NCI) to begin pre-clinical development of a targeted therapy for triple negative breast […]

Offshore Fund Seeks Investment in Small Micro Cap Companies

By Alexandra Barnes on November 20, 2016

Offshore Fund Seeks Investment in Small Micro Cap Companies Using Equity Financing Structure Investment Criteria: $1+ share price…lower stock price considered depending on liquidity, business model, management team, etc. Investment Size: generally $1 […]

Posts navigation

‹ Newer 1 … 24 25 26 27 28 29 30 31 32 33 34 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.